Skip to main content
SpringerLink
Log in

Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity

  • Biotechnologically relevant enzymes and proteins
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Antagonists of tumor necrosis factor alpha (TNFa) have revolutionized the treatment of selected inflammatory diseases. Recombination Camelidae variable heavy-chain domain-only TNFa antibodies (anti-TNF-VHH) have been developed to antagonize the action of human and murine TNFa. Here, we describe a strategy to obtain functional covalent dimer anti-TNF-VHH molecules with the C-terminal fusion of human IgG1 Fc domain named anti-TNF-VHH-Fc. The resulting fusion proteins were separately expressed by use of the pET28a vector in Escherichia coli (Ec) strain BL21 and the pPICZaA vector in Pichia pastoris (Pp) strain GS115, then purified by protein A affinity resin. Fc-engineered anti-EcTNF-VHH-Fc was about 40 kDa and anti-PpTNF-VHH-Fc was about 43 kDa. Monomeric VHH was also cloned and expressed in E. coli strain BL21, with the molecular weight of about 18 kDa. Enzyme-linked immunosorbent assay and L929 cell cytotoxicity assay demonstrated that the fusion protein anti-PpTNF-VHH-Fc blocked TNFa activity more effectively than either anti-EcTNF-VHH-Fc or monomeric anti-EcTNF-VHH protein. We suggest that efficient disulfide bond formation using the P. pastoris expression system improves the covalent dimer anti-TNF-VHH-Fc neutralizing activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Aggarwal BB, Gupta SC, Kim JH (2012) Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 119(3):651–665

    Article  PubMed  CAS  Google Scholar 

  • Ahmadvand D, Rasaee MJ, Rahbarizadeh F, Mohammadi M (2008) Production and characterization of a high-affinity nanobody against human endoglin. Hybridoma Larchmt 27(5):353–360

    Article  PubMed  CAS  Google Scholar 

  • Ameloot P, Brouckaert P (2004) Production and characterization of receptor-specific TNF muteins. Methods Mol Med 98:33–46

    PubMed  CAS  Google Scholar 

  • Arbabi Ghahroudi M, Desmyter A, Wyns L, Hamers R, Muyldermans S (1997) Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 414(3):521–526

    Article  PubMed  CAS  Google Scholar 

  • Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343(22):1586–1593

    Article  PubMed  CAS  Google Scholar 

  • Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11(9):372–377

    Article  PubMed  CAS  Google Scholar 

  • Cao P, Zhang S, Gong Z, Tang X, Cao M, Hu Y (2006) Development of a compact anti-BAFF antibody in Escherichia coli. Appl Microbiol Biotechnol 73(1):151–157

    Article  PubMed  CAS  Google Scholar 

  • Cao P, Zhang S, Fang Z, Huang H, Bai P, Zhang Q, Luo C (2008) Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS. Appl Microbiol Biotechnol 78(2):275–282

    Article  PubMed  CAS  Google Scholar 

  • Chauhan AK, Arora D, Khanna N (1999) A novel feeding strategy for enhanced protein production by fed-batch fermentation in recombinant Pichia pastoris. Process Biochem 34:139–145

    Article  CAS  Google Scholar 

  • Coppieters K, Dreier T, Silence K, de Haard H, Lauwereys M, Casteels P, Beirnaert E, Jonckheere H, Van de Wiele C, Staelens L, Hostens J, Revets H, Remaut E, Elewaut D, Rottiers P (2006) Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. Arthritis Rheum 54(6):1856–1866

    Article  PubMed  CAS  Google Scholar 

  • Els Conrath K, Lauwereys M, Wyns L, Muyldermans S (2001a) Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J Biol Chem 276(10):7346–7350

    Article  PubMed  CAS  Google Scholar 

  • Els Conrath K, Lauwereys M, Wyns L, Muyldermans S (2001b) Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J Biol Chem 276(10):7346–7350

    Article  PubMed  CAS  Google Scholar 

  • Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B (2008) Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372(9636):375–382

    Article  PubMed  CAS  Google Scholar 

  • Estell D (2006) Adapting industry practices for the rapid, large-scale manufacture of pharmaceutical proteins. Bridge 36:39–44

    Google Scholar 

  • Ezzine A, M’Hirsi El Adab S, Bouhaouala-Zahar B, Hmila I, Baciou L, Marzouki MN (2012) Efficient expression of the anti-AahI′ scorpion toxin nanobody under a new functional form in a Pichia pastoris system. Biotechnol Appl Biochem 59(1):15–21

    Article  PubMed  CAS  Google Scholar 

  • Floss DM, Kipriyanov S, Conrad U, Scheller J (2009) Covalent dimerization of Camelidae anti-human TNF-alpha single domain antibodies by the constant kappa light chain domain improves neutralizing activity. Biotechnol Bioeng 106(1):161–166

    Google Scholar 

  • Frenken LG, van der Linden RH, Hermans PW, Bos JW, Ruuls RC, de Geus B, Verrips CT (2000) Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol 78(1):11–21

    Article  PubMed  CAS  Google Scholar 

  • Freyre FM, Vazquez JF, Ayala M, Canaan-Haden L, Bell H, Rodriquez I, Gonzalez A, Cintado A, Gavilondo JV (2000) Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastoris. J Biotechnol 76:157–163

    Article  PubMed  CAS  Google Scholar 

  • Harmsen MM, De Haard HJ (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 77(1):13–22

    Article  PubMed  CAS  Google Scholar 

  • Harmsen MM, Van Solt CB, Fijten HP, Van Setten MC (2005) Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins. Vaccine 23(41):4926–4934

    Article  PubMed  CAS  Google Scholar 

  • Jauregui-Amezaga A, Turon F, Ordas I, Gallego M, Feu F, Ricart E, Panes J (2012) Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening. J Crohns Colitis. doi:10.1016/j.crohns.2012.05.012

  • Kosinski M, Kujawski SC, Martin R, Wanke LA, Buatti MC, Ware JE Jr, Perfetto EM (2002) Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response. Am J Manag Care 8(3):231–240

    PubMed  Google Scholar 

  • McMahon MS, Ueki Y (2008) Does anti-TNF-alpha have a role in the treatment of osteoporosis? Bull NYU Hosp Jt Dis 66(4):280–281

    PubMed  Google Scholar 

  • Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356(9227):385–390

    Article  PubMed  CAS  Google Scholar 

  • Migliore A, Massafra U, Carloni E, Padalino C, Martin Martin S, Lasaracina F, Dibiase N, Alimonti A, Granata M (2005) TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report. Eur Rev Med Pharmacol Sci 9(6):373–378

    PubMed  CAS  Google Scholar 

  • Mitoma H, Horiuchi T, Hatta N (2005) Infliximab induces potent antiinflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 128(2):376–392

    Article  PubMed  CAS  Google Scholar 

  • Muyldermans S, Baral TN, Retamozzo VC, De Baetselier P, De Genst E, Kinne J, Leonhardt H, Magez S, Nguyen VK, Revets H, Rothbauer U, Stijlemans B, Tillib S, Wernery U, Wyns L, Hassanzadeh-Ghassabeh G, Saerens D (2009) Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol 128(1–3):178–183

    Article  PubMed  CAS  Google Scholar 

  • Nixon R, Bansback N, Brennan A (2007) The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons. Rheumatology Oxford 46(7):1140–1147

    Article  PubMed  CAS  Google Scholar 

  • Olichon A, Schweizer D, Muyldermans S, de Marco A (2007) Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains. BMC Biotechnol 7:7

    Article  PubMed  Google Scholar 

  • Plagmann I, Chalaris A, Kruglov AA, Nedospasov S, Rosenstiel P, Rose-John S, Scheller J (2009) Transglutaminase-catalyzed covalent multimerization of Camelidae anti-human TNF single domain antibodies improves neutralizing activity. J Biotechnol 142(2):170–178

    Article  PubMed  CAS  Google Scholar 

  • Powers DB, Amersdorfer P, Poul MA, Nielsen UB, Shalaby MR, Adams GP, Weiner LM, Marks JD (2001) Expression of single-chain Fv–Fc fusions in Pichia pastoris. J Immunol Methods 251:123–135

    Article  PubMed  CAS  Google Scholar 

  • Rahbarizadeh F, Ahmadvand D, Sharifzadeh Z (2011) Nanobody; an old concept and new vehicle for immunotargeting. Immunol Invest 40(3):299–338

    Article  PubMed  CAS  Google Scholar 

  • Reff ME, Heard C (2001) A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications. Crit Rev Oncol Hematol 40(1):25–35

    Article  PubMed  CAS  Google Scholar 

  • Ridder R, Schmitz R, Legay F, Gram H (1995) Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Biotechnology N Y 13(3):255–260

    Article  PubMed  CAS  Google Scholar 

  • Rigby WF (2007) Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior? Nat Clin Pract Rheumatol 3(4):227–233

    Article  PubMed  CAS  Google Scholar 

  • Roovers RC, Laeremans T, Huang L, De Taeye S, Verkleij AJ, Revets H, De Haard HJ, Henegouwen PM VBe (2007) Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodies. Cancer Immunol Immunother 56(3):303–317

    Article  PubMed  CAS  Google Scholar 

  • Sberna GCR, Henry A, Small DH (1996) Advantages of the methylotrophic yeast Pichia pastoris for high-level expression and purification of heterologous proteins. Austral Biotechnol 6:282–287

    Google Scholar 

  • Sevastsyanovich Y, Alfasi S, Cole J (2009) Recombinant protein production: a comparative view on host physiology. N Biotechnol 25(4):175–180

    Article  PubMed  CAS  Google Scholar 

  • Son JH, Cha SW (2010) Anti-TNF-alpha therapy for ankylosing spondylitis. Clin Orthop Surg 2(1):28–33

    Article  PubMed  Google Scholar 

  • Strand V, Sharp V, Koenig AS, Park G, Shi Y, Wang B, Zack DJ, Fiorentino D (2012) Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Ann Rheum Dis 71(7):1143–1150

    Article  PubMed  CAS  Google Scholar 

  • Urra JM, Arteta M, Gomez-Caturla A, Garcia-Duran F (2001) A chimeric anti-TNFalpha monoclonal antibody (cA2) in vivo removes TNFalpha-producing cells in Crohn’s disease. Hum Antibodies 10(2):91–94

    PubMed  CAS  Google Scholar 

  • Vandenbroucke K, de Haard H, Beirnaert E, Dreier T, Lauwereys M, Huyck L, Van Huysse J, Demetter P, Steidler L, Remaut E, Cuvelier C, Rottiers P (2009) Orally administered L. lactis secreting an anti-TNF nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol 3(1):49–56

    Article  PubMed  Google Scholar 

  • Viola F, Civitelli F, Di Nardo G, Barbato MB, Borrelli O, Oliva S, Conte F, Cucchiara S (2009) Efficacy of adalimumab in moderate-to-severe pediatric Crohn’s disease. Am J Gastroenterol 104(10):2566–2571

    Article  PubMed  CAS  Google Scholar 

  • Wiedmann MW, Mossner J, Baerwald C, Pierer M (2009) TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases. Endocr Metab Immune Disord Drug Targets 9(3):295–314

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was funded by a grant from the National Science Foundation of China (NSFC; no. 30971486), the Priority Academic Program Development of Jiangsu Higher Education Institutions (no. 164320H106), and NSFC for Talents Training in Basic Science (no. J1103507).

Author information

Authors and Affiliations

  1. Jiang Su Province Key Laboratory for Molecular and Medical Biotechnology, Life Science College, Nanjing Normal University, Nanjing, 210046, Jiangsu, China

    Xuemei Ji, Huiting Zhou, Dongju Han, Lin Yang, Haitao Wu, Jianfeng Li, Hongyan Liu, Jie Zhang & Shuangquan Zhang

  2. Laboratory of Cellular and Molecular Biology, Jiangsu Province Institute of Traditional Chinese Medicine, Nanjing, 210028, Jiangsu, China

    Wuguang Lu & Peng Cao

Authors
  1. Xuemei Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wuguang Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huiting Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dongju Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lin Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Haitao Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jianfeng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hongyan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Peng Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shuangquan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Peng Cao or Shuangquan Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ji, X., Lu, W., Zhou, H. et al. Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity. Appl Microbiol Biotechnol 97, 8547–8558 (2013). https://doi.org/10.1007/s00253-012-4639-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-012-4639-2

Keywords

Search

Navigation